Our Team
Steven Feldon, MD, MBA
Director
Dr. Steven Feldon is the founding Director of the Office of Biomedical Research Development (BRDO). As an academic physician, the first 22 years of his career were spent at Doheny Eye Institute/University of Southern California School of Medicine where he was nationally and internationally recognized as a clinician and clinical researcher. This was highlighted by his work inventing and patenting commercialized medical instrumentation, entrepreneurism as Founder and CEO of Oculab, a medical device company and Documation, an electronic medical record company, and academic administrative expertise where he served as Medical Director of Doheny Medical Group, Chief of Staff Doheny Eye Hospital, Vice President Finance & Marketing, Doheny Medical Group.
Dr. Feldon was recruited by the University of Rochester School of Medicine & Dentistry in part due to his interest in innovation, entrepreneurism, and technology transfer. He joined the faculty as Professor and Chair of Ophthalmology and Director of the now-named David & Ilene Flaum Eye Institute in 2001. During his 18 year tenure, he grew the ophthalmology related annual revenues from $1.5 M to $55 M. He spearheaded an historic $5 M agreement with Bausch & Lomb to develop the Eye Institute into a world-class resource supporting eye research and development in Rochester, NY. He has fostered innovation with multiple patents awarded to him and to his faculty.
Kate Jordon, MSHSA
Administrator
Kate Jordon joined URMC and the Office of Biomedical Research Development in April, 2020 as the Office Administrator. She received her BS in Medical Technology and Biology from the State University of New York at Fredonia in 2015 followed by her MS in Health Systems Administration from Rochester Institute of Technology in 2020. She previously worked as an ASCP Board Certified Medical Laboratory Scientist in Transfusion Services at Rochester General Hospital where she formulated a standing operating procedure to resolve drug interference in laboratory testing, and created reference and product request forms to be used by all transfusion services across the Rochester Regional Health System. Through the MSHSA program at RIT, Kate gained experience in healthcare strategy, operations, and economics and policy. She now brings her scientific knowledge, clinical work experience, and up-to-date graduate school education to her new position as the Office Administrator for BRDO.
Paula Doyle, MD
Liaison Manager
Dr. Paula Jaye Doyle is a clinical researcher and innovator, who has joined the office part-time as Liaison Manager. In this new role, Dr. Doyle will serve as a bridge between faculty who have cutting edge technologies and clinicians that have identified a clinical need. Dr. Doyle is a nationally recognized Urogynecologist with a focus on reconstructive pelvic surgery. She is an Associate Professor in the Division of Female Pelvic Medicine and Reconstructive Surgery with appointments in both Urology and OB/Gyn at the University of Rochester. Her scholarly activities involve clinical research and innovation in medicine.
Dr. Doyle gained her initial experience as an innovator and entrepreneur by collaborating in the development of a polymer that fluoresces under near infrared imaging. This new type of polymer resulted in a patented instrument that localizes tumor tissue intraoperatively, leading to the launch of her start-up company, EndoGlow. Through the growth of EndoGlow, Dr. Doyle has firsthand knowledge of the balance between academic medicine and entrepreneurship. She has given lectures on medical entrepreneurship at Rochester Institute of Technology, Syracuse University and the University of Rochester School of Medicine and Dentistry. She continues to teach medical entrepreneurship and innovation on the national level through post-graduate coursework. Dr. Doyle brings her love of innovation and the creative scientific process to BRDO with the goal of bringing together highly skilled researchers and clinicians looking to advance patient care.